TC Biopharm (Holdings) Plc (NASDAQ:TCBP) Short Interest Update

TC Biopharm (Holdings) Plc (NASDAQ:TCBP) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 38,300 shares, a drop of 41.0% from the October 31st total of 64,900 shares. Based on an average daily volume of 1,230,000 shares, the days-to-cover ratio is currently 0.0 days.

TC Biopharm Stock Down 6.7 %

NASDAQ TCBP traded down $0.04 on Friday, reaching $0.56. 452,118 shares of the company were exchanged, compared to its average volume of 507,828. TC Biopharm has a fifty-two week low of $0.44 and a fifty-two week high of $80.00. The business’s fifty day moving average price is $2.94 and its 200 day moving average price is $6.14. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.88 and a current ratio of 0.88.

TC Biopharm Company Profile

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.